Biovail is a specialty pharmaceutical company founded in 1983, engaged in the formulation, clinical testing, registration, manufacturing, and commercialization of pharmaceutical products. The company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets within the manufacturing industry. Currently, there is no available information regarding the company's headquarters, last investment, or the last investment's investors.
There is no investment information
No recent news or press coverage available for Biovail.
We care about your data, and we'd love to use cookies make your experience better.
